| Altered metabolism of gut microbiota contributes to chronic immune activation in HIV-infected individuals JF Vázquez-Castellanos, S Serrano-Villar, A Latorre, A Artacho, ... Mucosal immunology 8 (4), 760-772, 2015 | 285 | 2015 |
| The CD4/CD8 ratio in HIV-infected subjects is independently associated with T-cell activation despite long-term viral suppression S Serrano-Villar, C Gutiérrez, A Vallejo, B Hernandez-Novoa, L Díaz, ... Journal of Infection 66 (1), 57-66, 2013 | 169 | 2013 |
| The effects of prebiotics on microbial dysbiosis, butyrate production and immunity in HIV-infected subjects S Serrano-Villar, JF Vázquez-Castellanos, A Vallejo, A Latorre, T Sainz, ... Mucosal immunology 10 (5), 1279-1293, 2017 | 118 | 2017 |
| Intensification of antiretroviral therapy with a CCR5 antagonist in patients with chronic HIV-1 infection: effect on T cells latently infected C Gutiérrez, L Díaz, A Vallejo, B Hernández-Novoa, M Abad, N Madrid, ... PloS one 6 (12), e27864, 2011 | 117 | 2011 |
| Premature immunosenescence in HIV-infected patients on highly active antiretroviral therapy with low-level CD4 T cell repopulation S Molina-Pinelo, A Vallejo, L Díaz, N Soriano-Sarabia, ... Journal of antimicrobial chemotherapy 64 (3), 579-588, 2009 | 86 | 2009 |
| The effect of intensification with raltegravir on the HIV-1 reservoir of latently infected memory CD4 T cells in suppressed patients A Vallejo, C Gutierrez, B Hernandez-Novoa, L Diaz, N Madrid, ... Aids 26 (15), 1885-1894, 2012 | 85 | 2012 |
| Influence of the Toll-like receptor 9 1635A/G polymorphism on the CD4 count, HIV viral load, and clinical progression N Soriano-Sarabia, A Vallejo, R Ramírez-Lorca, M del Mar Rodríguez, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 49 (2), 128-135, 2008 | 84 | 2008 |
| Mycosis fungoides and Sezary syndrome are not associated with HTLV‐I infection: an international study A Bazarbachi, V Soriano, R Pawson, A Vallejo, T Moudgil, E Matutes, ... British journal of haematology 98 (4), 927-933, 1997 | 78 | 1997 |
| Melatonin synthesized by Jurkat human leukemic T cell line is implicated in IL‐2 production PJ Lardone, A Carrillo‐Vico, MC Naranjo, B De Felipe, A Vallejo, ... Journal of cellular physiology 206 (1), 273-279, 2006 | 71 | 2006 |
| Correlation between different methods to measure microbial translocation and its association with immune activation in long-term suppressed HIV-1–infected individuals M Abad-Fernández, A Vallejo, B Hernández-Novoa, L Díaz, C Gutiérrez, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 64 (2), 149-153, 2013 | 69 | 2013 |
| Fecal microbiota transplantation in HIV: A pilot placebo-controlled study S Serrano-Villar, A Talavera-Rodríguez, MJ Gosalbes, N Madrid, ... Nature Communications 12 (1), 1139, 2021 | 64 | 2021 |
| Changes in the rate of genotypic resistance to antiretroviral drugs in Spain O Gallego, L Ruiz, A Vallejo, E Ferrer, A Rubio, B Clotet, M Leal, ... Aids 15 (14), 1894-1896, 2001 | 63 | 2001 |
| Development of a multiplex PCR assay for the simultaneous detection and discrimination of HIV-1, HIV-2, HTLV-I and HTLV-II A Heredia, V Soriano, SH Weiss, R Bravo, A Vallejo, TN Denny, ... Clinical and diagnostic virology 7 (2), 85-92, 1996 | 58 | 1996 |
| Thymic volume is associated independently with the magnitude of short- and long-term repopulation of CD4+ T cells in HIV-infected adults after highly active … E Ruiz-Mateos, A Rubio, A Vallejo, R De la Rosa, A Sanchez-Quijano, ... Clinical & Experimental Immunology 136 (3), 501-506, 2004 | 53 | 2004 |
| Effects of first-line antiretroviral therapy on the CD4/CD8 ratio and CD8 cell counts in CoRIS: a prospective multicentre cohort study S Serrano-Villar, J Martínez-Sanz, R Ron, A Talavera-Rodríguez, ... The lancet HIV 7 (8), e565-e573, 2020 | 48 | 2020 |
| Effects of immunonutrition in advanced human immunodeficiency virus disease: a randomized placebo-controlled clinical trial (Promaltia Study) S Serrano-Villar, M de Lagarde, J Vázquez-Castellanos, A Vallejo, ... Clinical Infectious Diseases 68 (1), 120-130, 2019 | 41 | 2019 |
| Rate of virological treatment failure and frequencies of drug resistance genotypes among human immunodeficiency virus-positive subjects on antiretroviral therapy in Spain O Gallego, L Ruíz, A Vallejo, B Clotet, M Leal, V Soriano Journal of clinical microbiology 40 (10), 3865-3866, 2002 | 41 | 2002 |
| Changes in the immune response after treatment with benznidazole versus no treatment in patients with chronic indeterminate Chagas disease A Vallejo, B Monge-Maillo, C Gutiérrez, FF Norman, R López-Vélez, ... Acta tropica 164, 117-124, 2016 | 39 | 2016 |
| COVID‐19 in hospitalized HIV‐positive and HIV‐negative patients: A matched study C Díez, J Del Romero‐Raposo, R Mican, JC López, JR Blanco, ... HIV medicine 22 (9), 867-876, 2021 | 33 | 2021 |
| Visceral leishmaniasis as an independent cause of high immune activation, T‐cell senescence, and lack of immune recovery in virologically suppressed HIV‐1‐coinfected patients JL Casado, M Abad‐Fernández, S Moreno, MJ Pérez‐Elías, A Moreno, ... HIV medicine 16 (4), 240-248, 2015 | 33 | 2015 |
